E. Premkumar Reddy

Dr. E. Premkumar Reddy is a biologist.

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

How to quickly check pipettes?

Weighing the right way

He obtained his Ph. D. in molecular biology in 1971 from the Osmania University, Hyderabad, India. After post-doctoral training in the United States of America at the UCLA School of Medicine and the National Cancer Institute (NCI), he joined the NCI, with which he was associated till 1984 as the chief of the molecular genetics section.

In 1984, he moved to Hoffman LaRoche Roche Institute of molecular biology as a full member and in 1986, he joined the Wistar Institute as their deputy director. In 1992, he was appointed as the Director of the Fels Institute for Cancer Research and Molecular Biology, which is affiliated with Temple University. Dr. Reddy served as a member of the board of directors of NIEHS from 1990-1995. He co-founded the international cancer journal Oncogene in 1986, for which he is currently the editor. In 1993, he was awarded the Scientific Achievement award by the American Cancer Society.

Dr. Reddy has published over 200 papers. The most notable of his findings are the molecular cloning and sequence determination of a number of viral oncogenes and their cellular homologues. In collaboration with Dr. Mariano Barbacid, he was also one of the first to demonstrate that ras genes are activated in human cancers by point mutations. His most recent findings include the generation of A-myb and CDK4 null mutant mice and delineation of the apoptotic mechanisms associated with hematopoietic cell death. His recent work centers around the role of cell cycle and apoptotic genes in cancer progression and as targets for the development of novel anticancer drugs. This work has led to the development of novel therapeutic agents that can differentially induce apoptosis in tumor cells and spare normal cells.

According to data published in 2000 by the Institute of Scientific Information, which compiled the list of most highly cited authors, Dr. Reddy was amongst the top 0.5% of the most highly cited authors in the world.